Laboratorios Leti
CompanySpain
Laboratorios Leti develops one asset, in phase 2 (olea europaea in allergy). Mostly other; based in Spain.
- 1
- Asset
- Furthest
- Phase 2
- 3
- Trials
- 0
- Signals
Pipeline
1Allergen extract immunotherapy for desensitization against olive pollen and grass allergy.
Phase 2, Other, allergy, rhinitis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials3
Updated 7 Oct 2026 · 6 sources